Identification of Rigosertib for the Treatment of Recessive Dystrophic Epidermolysis Bullosa–Associated Squamous Cell Carcinoma

Velina S. Atanasova, Celine Pourreyron, Mehdi Farshchian, Michael E. Lawler, Christian A. Brown, Stephen Watt, Sheila Wright, Michael Warkala, Christina Guttmann-Gruber, Josefina Pinon-Hofbauer, Ignacia Fuentes, Marco Prisco, Elham Rashidghamat, Cristina Has, Julio C. Salas-Alanis, Francis Palisson, Alain Hovnanian, John A. McGrath, Jemima Mellerio, Johann W. BauerAndrew P. South (Lead / Corresponding author)

    Research output: Contribution to journalArticlepeer-review

    25 Citations (Scopus)
    95 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'Identification of Rigosertib for the Treatment of Recessive Dystrophic Epidermolysis Bullosa–Associated Squamous Cell Carcinoma'. Together they form a unique fingerprint.

    Keyphrases

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science